Biogen Inc.

NASDAQ: BIIB · Real-Time Price · USD
137.52
2.58 (1.91%)
At close: Aug 15, 2025, 1:11 PM

Biogen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.38B 1.05B 3.42B 2.26B
Short-Term Investments
n/a n/a 1.47B 1.54B
Long-Term Investments
226.7M 460.7M 705.7M 2.6B
Other Long-Term Assets
333.8M 284.3M 705.7M 229.3M
Receivables
1.87B 2.1B 2.14B 1.96B
Inventory
2.46B 2.53B 1.34B 1.35B
Other Current Assets
752.5M 1.18B 1.42B 740.8M
Total Current Assets
7.46B 6.86B 9.79B 7.86B
Property-Plant & Equipment
3.54B 3.73B 3.7B 3.79B
Goodwill & Intangibles
16.17B 14.58B 7.6B 7.98B
Total Long-Term Assets
20.59B 19.99B 14.76B 16.02B
Total Assets
28.05B 26.84B 24.55B 23.88B
Account Payables
424.2M 403.3M 491.5M 589.2M
Deferred Revenue
n/a 3M n/a n/a
Short-Term Debt
1.75B 150M 97.2M 999.1M
Other Current Liabilities
375.8M 1.34B 1.19B 1.24B
Total Current Liabilities
5.53B 3.43B 3.27B 4.3B
Long-Term Debt
4.55B 6.79B 6.28B 6.27B
Other Long-Term Liabilities
732.3M 781.1M 944.2M 1.32B
Total Long-Term Liabilities
5.8B 8.61B 7.89B 8.62B
Total Liabilities
11.33B 12.05B 11.17B 12.92B
Total Debt
6.63B 7.34B 6.61B 7.6B
Common Stock
100K 100K 100K 100K
Retained Earnings
19.26B 17.63B 16.47B 13.91B
Comprehensive Income
-136.2M -153.7M -164.9M -106.7M
Shareholders Equity
16.72B 14.8B 13.4B 10.9B
Total Investments
n/a 460.7M 2.18B 4.37B